FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health Organization.
作者信息
Ahlgren J D, Smith F P, Cazap E, Estevez R A, Marantz A, Woolley P V, Wilcosky T, Stein J, Schein P S